Antitrust Group Backs Cipro Buyers In Pay-For-Delay Row
The American Antitrust Institute and a group of nearly 50 professors on Tuesday urged California's highest court to revive a pay-for-delay antitrust case over the drug Cipro, arguing that a lower...To view the full article, register now.
Already a subscriber? Click here to view full article